Skip to main
BBLG
BBLG logo

BBLG P/E Ratio

P/E Ratio as of Jul 22, 2025: -0.13

Average-0.1543
Median-0.1300
Minimum-0.2700
Maximum-0.1200
-0.13
Past Month+0.12 (48.00%)
The P/E ratio for BBLG is -0.13 as of Jul 22, 2025. This represents a decrease of -35.00% compared to its 12-month average P/E ratio of -0.2. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Bone Biologics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Bone Biologics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bone Biologics Corp to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BBLG P/E Ratio Historic Data

DateStock priceP/E ratio
Jul 1, 2025$3.68-0.16
Jun 2, 2025$4.9182-0.21
May 1, 2025$4.20-0.18
Apr 1, 2025$5.01-0.22
Mar 3, 2025$4.929-0.17
Feb 3, 2025$7.62-0.26
Jan 2, 2025$5.8914-0.20

BBLG End of Year P/E Ratio

DateP/E ratioChange
2025-0.13-31.58%
2024-0.19+137.50%
2023-0.08-90.59%
2022-0.85-87.70%
2021-6.91-81.28%
2020-36.92

FAQs About Bone Biologics Corp (BBLG) P/E ratio

The latest P/E ratio of BBLG is -0.13, as of Jul 22, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Bone Biologics Corp’s last 12-month average P/E ratio is -0.2, compared to its current P/E ratio of -0.13. This reflects a decrease of -35.00%.

Bone Biologics Corp’s current P/E ratio of -0.13 is lower than its last 12-month average P/E of -0.2. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Bone Biologics Corp’s average P/E ratio over the last 3 years is -0.72. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Bone Biologics Corp’s average P/E ratio over the last 5 years is -9.47. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Bone Biologics Corp (BBLG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.